Skip to main content
Cancer Explained
Donate
Beginner 6 min readSource checked

Talcum Powder & Ovarian Cancer Risk: Evidence

IARC calls talc probably carcinogenic based on ovarian cancer studies, but causation is unproven. What the evidence does and does not show.

Source

IARC Monographs, Volume 136 (2024)

A nurse placing a blood pressure cuff on a patient's arm in an exam room
Nurse Checking Vital Signs

Key fact

In July 2024 IARC classified talc as probably carcinogenic to humans (Group 2A), based mainly on studies of genital powder use and ovarian cancer.

The short answer

Studies consistently find more ovarian cancer among women who used genital talc, which is why IARC calls talc probably carcinogenic. Causation is unproven and the absolute risk difference is small.

  • In July 2024 IARC classified talc as probably carcinogenic to humans (Group 2A), based mainly on studies of genital powder use and ovarian cancer.

  • IARC graded the human evidence as limited, not sufficient, because reporting bias could not be ruled out with reasonable confidence and asbestos contamination could not be excluded in most studies.

  • Most of the studies showing a link asked women to recall powder use from decades earlier after a cancer diagnosis, which invites recall bias.

  • A pooled analysis of four large cohorts following 252,745 women found 61 ovarian cancers per 100,000 person-years among ever-users versus 55 among never-users, a hazard ratio of 1.08 (95% CI 0.99 to 1.17) that was not statistically significant.

Choose how you want to understand this

The full explanation.

The claim

Using talcum powder in the genital area causes ovarian cancer.

What the evidence shows

In July 2024 the International Agency for Research on Cancer classified talc as probably carcinogenic to humans. That is its Group 2A category. The human evidence behind the decision was specifically about ovarian cancer. IARC pointed to numerous studies. They consistently showed an increase in ovarian cancer among people who reported using body powder in the perineal region.

Group 2A is a statement about how strong the evidence is. It is not a statement about how much risk any individual faces. IARC was careful about what it could not rule out. It graded the human evidence as limited rather than sufficient. One reason was bias in how talc use was reported in the studies, which could not be ruled out with reasonable confidence. Another was that contamination of talc with asbestos could not be excluded in most of them. Asbestos is a known carcinogen. It occurs naturally in the ground near talc deposits.

Study design matters a great deal here. Most of the studies showing a link asked women who already had ovarian cancer to remember powder use from decades earlier. Their answers were then compared with those of women who did not have cancer. People searching for an explanation for a diagnosis may recall past exposures differently. That is recall bias, and it can create an apparent association on its own.

Studies that recorded powder use before anyone became ill have generally been more reassuring. A pooled analysis of four large cohorts followed 252,745 women for a median of about 11 years. Among women who had ever used genital powder, ovarian cancer occurred in 61 per 100,000 person-years. Among those who had not, it was 55 per 100,000. The hazard ratio was 1.08, with a confidence interval of 0.99 to 1.17. That did not reach statistical significance. The authors noted the study may still have been underpowered to detect a small increase.

More recent work has complicated the picture again. A 2024 analysis of the Sister Study tried to correct mathematically for misreporting. It still produced estimates above 1.0. Meanwhile NCI's patient summary says studies of perineal talc have not found clear evidence of an increased risk of ovarian cancer. FDA says a link has not been conclusively demonstrated, and that more research is needed.

Putting the size of it in perspective

Take the higher estimates at face value, and the absolute difference is still small. In the pooled cohort analysis, the estimated difference in ovarian cancer risk by age 70 was roughly 0.09 percentage points. Ovarian cancer is uncommon. A modest relative increase in an uncommon disease is still an uncommon outcome.

What this does not mean

A Group 2A label does not mean talc has been shown to cause ovarian cancer. It does not mean past use has harmed you. And there is no test or treatment recommended on the basis of talc use.

It also does not mean the question is settled in the other direction. The association keeps appearing, and IARC found it consistent enough to act on. The label also does not name the culprit. If there is a real effect, asbestos contamination rather than talc itself remains a live explanation.

The bottom line

The honest answer is unproven. Studies consistently find somewhat more ovarian cancer among women who used genital talc. That is why IARC calls talc probably carcinogenic. But recall bias and possible asbestos contamination mean causation has not been established. And in the best-designed studies the absolute risk difference is small. Avoiding talc is a reasonable personal choice, and cornstarch-based powders are an alternative. Is ovarian cancer risk on your mind? The factors with the clearest evidence are the ones worth raising with your clinician. Those include family history, BRCA1 and BRCA2 changes, and endometriosis.

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

An empty hospital reflection room with two chairs, a lamp, a plant and a candle

Common questions

Does genital talc use cause ovarian cancer?

That has not been established. Studies consistently find somewhat more ovarian cancer among women who report using genital powder, which is why IARC classified talc as probably carcinogenic in 2024. But IARC could not rule out two other explanations: contamination of the talc with asbestos, and bias in how women recalled their past use. Causation remains unproven.

What does Group 2A actually mean?

It describes how strong the evidence is that something can cause cancer, not how much risk you personally face. Group 2A means probably carcinogenic. It does not quantify risk, and it does not distinguish between a large hazard and a very small one.

How big is the possible risk?

Small in absolute terms. In the largest pooled cohort analysis, ovarian cancer occurred in 61 per 100,000 person-years among women who had ever used genital powder and 55 per 100,000 among those who had not, a difference that was not statistically significant. The estimated difference in risk by age 70 was about 0.09 percentage points.

Why do different study types disagree?

Studies that ask women with ovarian cancer to remember powder use from decades earlier tend to find a link. Studies that recorded powder use before anyone became ill have generally not found a significant increase overall. People searching for an explanation for a diagnosis may remember past exposures differently, and that difference alone can create an apparent association.

I used talc for years. What should I do now?

Nothing about this evidence says you have been harmed, and there is no test or treatment recommended on the basis of past talc use. If ovarian cancer is on your mind, the more useful conversation with your clinician is about the factors with clearer evidence: family history, BRCA1 and BRCA2, and endometriosis. Anyone who prefers to avoid talc can use a cornstarch-based powder.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

What the evidence shows about common cancer claims.

Explore more claim checks
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from IARC Monographs, Volume 136 (2024) material and checked line by line against the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Written by: Cancer ExplainedSources last checked: 2026-07-30 what this meansLast updated: 2026-08-10Next planned review: 2027-01-30

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.